AstraZeneca’s ‘Truqap’, or capivasertib, in combination with ‘Faslodex’, or fulvestrant, has secured approval from the US Food and Drug Administration (FDA) for specific breast cancer treatments, the company announced on Friday.
/PRNewswire/ SINGAPORE patients with an aggressive form of lung cancer (metastatic small cell lung cancer) can now access a new therapy that may improve.
New Therapy to Treat Advanced Small Cell Lung Cancer Approved for Australian Patients prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
New Therapy to Treat Advanced Small Cell Lung Cancer Approved for Australian Patients fnarena.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fnarena.com Daily Mail and Mail on Sunday newspapers.